Elucidating the role played by bone marrow in visceral leishmaniasis

Front Cell Infect Microbiol. 2023 Oct 4:13:1261074. doi: 10.3389/fcimb.2023.1261074. eCollection 2023.

Abstract

Leishmaniasis is a widespread group of infectious diseases that significantly impact global health. Despite high prevalence, leishmaniasis often receives inadequate attention in the prioritization of measures targeting tropical diseases. The causative agents of leishmaniasis are protozoan parasites of the Leishmania genus, which give rise to a diverse range of clinical manifestations, including cutaneous and visceral forms. Visceral leishmaniasis (VL), the most severe form, can be life-threatening if left untreated. Parasites can spread systemically within the body, infecting a range of organs, such as the liver, spleen, bone marrow and lymph nodes. Natural reservoirs for these protozoa include rodents, dogs, foxes, jackals, and wolves, with dogs serving as the primary urban reservoir for Leishmania infantum. Dogs exhibit clinical and pathological similarities to human VL and are valuable models for studying disease progression. Both human and canine VL provoke clinical symptoms, such as organ enlargement, fever, weight loss and abnormal gamma globulin levels. Hematologic abnormalities have also been observed, including anemia, leukopenia with lymphocytosis, neutropenia, and thrombocytopenia. Studies in dogs have linked these hematologic changes in peripheral blood to alterations in the bone marrow. Mouse models of VL have also contributed significantly to our understanding of the mechanisms underlying these hematologic and bone marrow abnormalities. This review consolidates information on hematological and immunological changes in the bone marrow of humans, dogs, and mice infected with Leishmania species causing VL. It includes findings on the role of bone marrow as a source of parasite persistence in internal organs and VL development. Highlighting gaps in current knowledge, the review emphasizes the need for future research to enhance our understanding of VL and identify potential targets for novel diagnostic and therapeutic approaches.

Keywords: Leishmania; bone marrow; canine visceral leishmaniasis; human visceral leishmaniasis; visceral leishmaniasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Marrow / parasitology
  • Bone Marrow / pathology
  • Dog Diseases* / epidemiology
  • Dogs
  • Humans
  • Leishmania infantum*
  • Leishmaniasis* / pathology
  • Leishmaniasis, Visceral* / diagnosis
  • Leishmaniasis, Visceral* / veterinary
  • Mice
  • Skin / pathology

Grants and funding

This work was supported by grants from the Bahia State Research Support Foundation (5869/2015) and from Gonçalo Moniz Institute-FIOCRUZ Bahia (IGM-002-FIO-20-2-22); PSTV holds a grant (305235/2019-2) from National Council for Scientific and Technological Development (CNPq); MdS is a Postdoctoral research financed by Fiocruz support foundation (FIOTEC); HT is a Postdoctoral research financed by the Fiocruz Inova Program; PSTV, CIB, DBMF and JPBDM are professors from PGPAT and PGBSMI financed by Higher Education Personnel Council–Brazil (CAPES)—Finance Code 001.